Top-News

Traws Pharma Aktie News

Aktie
WKN:  A40PJ7 ISIN:  US68232V8845 US-Symbol:  TRAW Branche:  Biotechnologie Land:  USA
2,35 $
+0,02 $
+0,86%
2,0017 € 12.12.25
Depot/Watchlist
Marktkapitalisierung *
3,63 Mio. €
Streubesitz
63,15%
KGV
-0,16
Index-Zuordnung
-

Traws Pharma News

30.10.25 - PR Newswire
ChemDiv Extends CMC Services Collaboration for Ratutrelvir, a Potential Best-in-Class COVID-19 Therapeutic Advancing in Phase 2 Clinical Trials
ChemDiv Extends CMC Services Collaboration for Ratutrelvir, a Potential Best-​in-Class COVID-19 Therapeutic Advancing in Phase 2 Clinical Trials PR Newswire
22.10.25 - PR Newswire
Dover, Delaware -- Expert Systems Inc., a leading life sciences accelerator, Supports Traws Pharma Phase 2 Clinical Studies of Ratutrelvir -- a Novel Ritonavir-Free Antiviral for COVID-19.
Dover, Delaware -- Expert Systems Inc., a leading life sciences accelerator, Supports Traws Pharma Phase 2 Clinical Studies of Ratutrelvir -- a Novel Ritonavir-​Free Antiviral for ...
23.01.25 - PR Newswire
Traws Pharma Announces Completion of Phase I Studies with Tivoxavir Marboxil, a Single Dose Oral Investigational Drug for the Treatment and Prevention of H5N1 Bird Flu
Traws Pharma Announces Completion of Phase I Studies with Tivoxavir Marboxil, a Single Dose Oral Investigational Drug for the Treatment and Prevention of H5N1 Bird Flu PR ...
10.01.25 - PR Newswire
Expert Systems and Traws Pharma Report Breakthrough in H5N1Bird Flu Antiviral Program
Expert Systems and Traws Pharma Report Breakthrough in H5N1Bird Flu Antiviral Program PR Newswire
30.12.24 - PR Newswire
Traws Pharma, Inc. Announces Financing up to $72.6 Million from Leading Healthcare Institutional Investors to Advance Tivoxavir Marboxil Development for H5N1 Bird Flu to Approval
Traws Pharma, Inc. Announces Financing up to $72.6 Million from Leading Healthcare Institutional Investors to Advance Tivoxavir Marboxil Development for H5N1 Bird Flu to Approval ...
23.12.24 - PR Newswire
Traws Pharma Announces Progress in Developing Tivoxavir Marboxil for H5N1 Bird Flu
Traws Pharma Announces Progress in Developing Tivoxavir Marboxil for H5N1 Bird Flu PR Newswire

Newssuche

Videos

newspaper
12.12.25 +5,87%
Technical Trading: Neues Allzeithoch im Visier
Gold Long Typ: Turbo Open End WKN: VC5S7W Hebel: 2 Laufzeit: OpenEnd Einstieg: Market ... Mehr »
Anzeige

Aktie im Fokus

Breaking News
ParaZero Technologies Ltd
1,09 €
-2,68%
ParaZero Technologies Ltd Chart
Parazero Technologies und die Bundespolizei!
Mehr zur Aktie »